Log in to search using one of your social media accounts:

 

Monthly News Roundup - January 2018
Opdivo Gains New Adjuvant Use in Melanoma Adjuvant therapy can reduce the risk of cancer recurrence follow surgery that removes the tumor and lymph nodes. Bristol-Myers Squibb’s Opdivo (nivolumab) is now the first PD-1 inhibitor approved as... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 31, 2018 Category: Pharmaceuticals Source Type: news

FDA, FTC Warn Companies for Selling Illegal, Unapproved Opioid Cessation Products Using Deceptive Claims
January 24, 2018 -- The U.S. Food and Drug Administration and the Federal Trade Commission today posted joint warning letters to the marketers and distributors of 12 opioid cessation products, for illegally marketing unapproved products with claims... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 24, 2018 Category: Pharmaceuticals Source Type: news

Monthly News Roundup - December 2017
Luxturna Gene Therapy OK ’d for Rare Form of Vision Loss A historic approval, Luxturna (voretigene neparvovec-rzyl) from Spark Therapeutics is the first directly administered gene therapy that targets a disease caused by specific gene... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 31, 2017 Category: Pharmaceuticals Source Type: news

FDA Permits Marketing of Device to Treat Diabetic Foot Ulcers
December 28, 2017 -- Today, the U.S. Food and Drug Administration permitted the marketing of the Dermapace System, the first shock wave device intended to treat diabetic foot ulcers. “Diabetes is the leading cause of lower limb amputations,”... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 28, 2017 Category: Pharmaceuticals Source Type: news

FDA Clears Stereotactic Radiotherapy System for Use in Treating Breast Cancer
December 22, 2017 -- Today, the U.S. Food and Drug Administration cleared a new noninvasive stereotactic radiotherapy system intended for use in treating cancer in breast tissue. “With today’s clearance, patients will have access to a treatment... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 22, 2017 Category: Pharmaceuticals Source Type: news

FDA Proposes New, Risk-Based Enforcement Priorities to Protect Consumers from Potentially Harmful, Unproven Homeopathic Drugs
December 18, 2017 - Today, the U.S. Food and Drug Administration proposed a new, risk-based enforcement approach to drug products labeled as homeopathic. To protect consumers who choose to use homeopathic products, this proposed new approach would... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 18, 2017 Category: Pharmaceuticals Source Type: news

FDA Launches New Tool for Sharing Information That Allows Doctors to Better Manage Antibiotic Use
December 13, 2017 -- Today the U.S. Food and Drug Administration is announcing a new approach to get critical updates regarding antibiotics and antifungal drugs to health care professionals as part of an overall effort to combat antimicrobial... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 13, 2017 Category: Pharmaceuticals Source Type: news

FDA Warns Companies for Promoting Alternatives to Street Drugs
December 12, 2017 -- The U.S. Food and Drug Administration today posted a warning letter to the marketers and distributors of Legal Lean Syrup, a drink, and Coco Loko, a “snortable” chocolate powder, for selling unapproved new drugs and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 12, 2017 Category: Pharmaceuticals Source Type: news

Monthly News Roundup - November 2017
FDA Approves Juluca, a Novel 2-Drug Regimen for HIV-1 Infection In November, the U.S. Food and Drug Administration (FDA) approved ViiV Healthcare ’s Juluca (dolutegravir and rilpivirine), a single-tablet, two-drug regimen of dolutegravir... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 30, 2017 Category: Pharmaceuticals Source Type: news

FDA Grants Marketing Authorization of the First Device for Use in Helping to Reduce the Symptoms of Opioid Withdrawal
November 15, 2017 -- Today, the U.S. Food and Drug Administration granted a new indication to an electric stimulation device for use in helping to reduce the symptoms of opioid withdrawal. “Given the scope of the epidemic of opioid addiction, we... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 15, 2017 Category: Pharmaceuticals Source Type: news

FDA Warns Companies Marketing Unproven Products, Derived From Marijuana, that Claim to Treat or Cure Cancer
November 1, 2017 -- As part of the U.S. Food and Drug Administration ’s ongoing efforts to protect consumers from health fraud, the agency today issued warning letters to four companies illegally selling products online that claim to prevent,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 1, 2017 Category: Pharmaceuticals Source Type: news

Monthly News Roundup - October 2017
Yescarta CAR T-Cell Therapy Approved for Lymphoma Novel chimeric antigen receptor T cell (CAR T) therapy allows patients with certain blood cancers -- but limited treatment options -- to achieve remission. The U.S. Food and Drug Administration... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 31, 2017 Category: Pharmaceuticals Source Type: news

Monthly News Roundup - September 2017
FDA Approves Lilly ’s Verzenio: Targeted Breast Cancer Treatment Lilly’s Verzenio (abemaciclib), a CDK 4/6 inhibitor breast cancer treatment, has been FDA-approved. Verzenio is used in 2 patient populations: either with fulvestrant (Faslodex)... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 30, 2017 Category: Pharmaceuticals Source Type: news

FDA Improves Access to Reports of Adverse Drug Reactions
September 28, 2017 -- The U.S. Food and Drug Administration today launched a new user-friendly search tool that improves access to data on adverse events associated with drug and biologic products through the FDA ’s Adverse Event Reporting System... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 28, 2017 Category: Pharmaceuticals Source Type: news

FDA Approves First Continuous Glucose Monitoring System for Adults Not Requiring Blood Sample Calibration
September 27, 2017 -- The U.S. Food and Drug Administration today approved the FreeStyle Libre Flash Glucose Monitoring System, the first continuous glucose monitoring system that can be used by adult patients to make diabetes treatment decisions... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 27, 2017 Category: Pharmaceuticals Source Type: news

FDA Conducts Major Global Operation to Protect Consumers From Potentially Dangerous Prescription Drugs Sold Online
September 25, 2017 -- The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, recently took action against more than 500 websites that illegally sell potentially dangerous, unapproved... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 25, 2017 Category: Pharmaceuticals Source Type: news

Teva Announces Reintroduction of Generic Depo-Provera in the United States
JERUSALEM--(BUSINESS WIRE)--Sep. 25, 2017-- Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) today announced the reintroduction of the generic equivalent to Depo-Provera1 Contraceptive Injection (medroxyprogesterone acetate injectable suspension,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 25, 2017 Category: Pharmaceuticals Source Type: news

Criminal and Civil Actions Filed Against Aegerion Pharmaceuticals Inc.
September 22, 2017 -- Today, Aegerion Pharmaceuticals Inc. agreed to plead guilty in the United States District Court for the District of Massachusetts to two misdemeanor counts of violating the Federal Food, Drug, and Cosmetic Act (FD&C Act)... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 22, 2017 Category: Pharmaceuticals Source Type: news

Monthly News Roundup - August 2017
Kymriah from Novartis Approved as First U.S. CAR-T Cell Therapy History was made this month as the U.S. Food and Drug Administration (FDA) approved the first U.S. cell-based gene therapy known collectively as chimeric antigen receptor (CAR)... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 31, 2017 Category: Pharmaceuticals Source Type: news

FDA provides new tools for the development and proper evaluation of tests for detecting Zika virus infection
August 17, 2017 -- As an additional measure in the fight against Zika virus, today the U.S. Food and Drug Administration announced that it has made available a panel of human plasma samples to aid in the regulatory evaluation of serological tests to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 17, 2017 Category: Pharmaceuticals Source Type: news

FDA Warns of Potential Contamination in Multiple Brands of Drugs, Dietary Supplements
August 11, 2017 -- The U.S. Food and Drug Administration is advising consumers and health care professionals not to use any liquid drug or dietary supplement products manufactured by PharmaTech LLC of Davie, Florida, and labeled by Rugby... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 11, 2017 Category: Pharmaceuticals Source Type: news

Monthly News Roundup - July 2017
FDA Approves Gilead ’s Vosevi for Six Hepatitis C Genotypes The U.S. Food and Drug Administration (FDA) has approved Gilead’s Vosevi (sofosbuvir, velpatasvir and voxilaprevir) for retreatment of adults with chronic hepatitis C virus (HCV) of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 31, 2017 Category: Pharmaceuticals Source Type: news

FDA Clears First Neonatal Magnetic Resonance Imaging Device
July 20, 2017 -- Today, the U.S. Food and Drug Administration cleared the first magnetic resonance imaging (MRI) device specifically for neonatal brain and head imaging in neonatal intensive care units (NICU). “Although we can use traditional MRI... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 20, 2017 Category: Pharmaceuticals Source Type: news

Endo Provides Update On Opana ER
DUBLIN, July 6, 2017 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) continues to believe in the safety, efficacy, and favorable benefit-risk profile of Opana ER (oxymorphone hydrochloride extended release) when used as intended, and notes... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 6, 2017 Category: Pharmaceuticals Source Type: news

FDA Clears Expanded Use of Cooling Cap to Reduce Hair Loss During Chemotherapy
July 3, 2017 -- Today, the U.S. Food and Drug Administration cleared the expanded use of a cooling cap, DigniCap Cooling System, to reduce hair loss (alopecia) during chemotherapy. This is the first cooling cap cleared by the agency for use in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 3, 2017 Category: Pharmaceuticals Source Type: news

Monthly News Roundup - June 2017
New Fluoroquinolone Baxdela Approved for Certain Skin Infections Roughly 3 million patients are hospitalized each year in the U.S. with acute bacterial skin and skin structure infections (ABSSSIs), some of which may be difficult-to-treat and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 30, 2017 Category: Pharmaceuticals Source Type: news

FDA Allows Marketing of Test to Aid in the Detection of Certain Leukemias and Lymphomas
June 29, 2017 -- The U.S. Food and Drug Administration today allowed marketing of ClearLLab Reagents (T1, T2, B1, B2, M), the first agency authorized test for use with flow cytometry to aid in the detection of several leukemias and lymphomas,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 29, 2017 Category: Pharmaceuticals Source Type: news

FDA Unveils Plan to Eliminate Orphan Designation Backlog
June 29, 2017 -- Today, the U.S. Food and Drug Administration unveiled a strategic plan to eliminate the agency ’s existing orphan designation request backlog and ensure continued timely response to all new requests for designation with firm... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 29, 2017 Category: Pharmaceuticals Source Type: news

FDA Tackles Drug Competition to Improve Patient Access
June 27, 2017 -- Today, the U.S. Food and Drug Administration is taking two new, important steps to increase competition in the market for prescription drugs and facilitate entry of lower-cost alternatives. The agency published a list of off-patent,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 27, 2017 Category: Pharmaceuticals Source Type: news

Sonar Products Ordered to Cease Operations, Stratus Pharmaceuticals Ordered to Cease Distributing Unapproved Drugs
June 15, 2017 -- Today, U.S. District Judge Kathleen M. Williams for the Southern District of Florida entered a consent decree of permanent injunction between the United States and Stratus Pharmaceuticals Inc. of Miami, Florida, Sonar Products Inc.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 15, 2017 Category: Pharmaceuticals Source Type: news

FDA Requests Removal of Opana ER for Risks Related to Abuse
June 8, 2017 -- Today, the U.S. Food and Drug Administration requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market. After careful consideration, the agency is... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 8, 2017 Category: Pharmaceuticals Source Type: news

FDA Approves First Generic Truvada for HIV Infection and Pre-Exposure Prophylaxis (PrEP)
June 8, 2017 - The U.S. Food and Drug Administration has approved the first generic version of Truvada for the treatment of HIV-1, in combination with other antiretroviral agents, and for pre-exposure prophylaxis (PrEP) in combination with safer sex... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 8, 2017 Category: Pharmaceuticals Source Type: news

Monthly News Roundup - May 2017
Actemra: First Drug Approved to Treat Giant Cell Arteritis Actemra (tocilizumab) from Hoffman La Roche has gained a new indication as the first drug approved to treat adults with giant cell arteritis, a specific type of vasculitis. Vasculitis is... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 30, 2017 Category: Pharmaceuticals Source Type: news

FDA Approves First Generic Strattera for the Treatment of ADHD
May 30, 2017 -- The U.S. Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients. Apotex Inc., Teva Pharmaceuticals... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 30, 2017 Category: Pharmaceuticals Source Type: news

FDA Warns Americans About Risk of Inaccurate Results from Certain Lead Tests
May 17, 2017 -- The U.S. Food and Drug Administration and Centers for Disease Control and Prevention are warning Americans that certain lead tests manufactured by Magellan Diagnostics may provide inaccurate results for some children and adults in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 17, 2017 Category: Pharmaceuticals Source Type: news

FDA Authorizes Use of New Device to Treat Esophageal Birth Defect in Babies
May 12, 2017 -- The U.S. Food and Drug Administration today authorized use of the Flourish Pediatric Esophageal Atresia Anastomosis, a first-of-its-kind medical device to treat infants up to one year old for a birth defect that causes a gap in their... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 12, 2017 Category: Pharmaceuticals Source Type: news

Monthly News Roundup - April 2017
Takeda Announces FDA Accelerated Approval of Alunbrig The US Food and Drug Administration (FDA) has approved once-daily oral Alunbrig (brigatinib) for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 30, 2017 Category: Pharmaceuticals Source Type: news

FDA Approves Two Hepatitis C Drugs - Sovaldi and Harvoni - for Pediatric Patients
April 7, 2017 -- The U.S. Food and Drug Administration today approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus (HCV) in children ages 12 to 17. Harvoni and Sovaldi were... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 7, 2017 Category: Pharmaceuticals Source Type: news

FDA Allows Marketing of First Direct-to-Consumer Tests that Provide Genetic Risk Information for Certain Conditions
April 6, 2017 -- The U.S. Food and Drug Administration today allowed marketing of 23andMe Personal Genome Service Genetic Health Risk (GHR) tests for 10 diseases or conditions. These are the first direct-to-consumer (DTC) tests authorized by the FDA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 6, 2017 Category: Pharmaceuticals Source Type: news

FDA Alerts Consumers of Nationwide Voluntary Recall of EpiPen and EpiPen Jr
March 31, 2017 -- The U.S. Food and Drug Administration is alerting consumers to Meridian Medical Technologies ’ voluntary recalldisclaimer icon of 13 lots of Mylan’s EpiPen and EpiPen Jr (epinephrine injection) Auto-Injector products used for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 31, 2017 Category: Pharmaceuticals Source Type: news

Monthly News Roundup - March 2017
Ocrevus Approved for Novel Use Among Multiple Sclerosis Treatments The much anticipated multiple sclerosis (MS) treatment Ocrevus (ocrelizumab) was given the green light from the FDA this month. Ocrevus is a humanized monoclonal antibody designed... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 31, 2017 Category: Pharmaceuticals Source Type: news

Monthly News Roundup - February 2017
FDA Approves Once-Daily Qtern Tablets for Adults with Type 2 Diabetes The U.S. Food and Drug Administration (FDA) has cleared AstraZeneca’s Qtern (dapagliflozin and saxagliptin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor and dipeptidyl... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 28, 2017 Category: Pharmaceuticals Source Type: news

FDA Clears Test to Help Manage Antibiotic Treatment for Lower Respiratory Tract Infections and Sepsis
February 23, 2017 -- The U.S. Food and Drug Administration today cleared the expanded use of the Vidas Brahms PCT Assay to help health care providers determine if antibiotic treatment should be started or stopped in patients with lower respiratory... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 23, 2017 Category: Pharmaceuticals Source Type: news

FDA Allows Marketing of Test to Identify Organisms That Cause Bloodstream Infections and Provide Antibiotic Sensitivity Results
February 23, 2017 -- The U.S. Food and Drug Administration today allowed marketing of the PhenoTest BC Kit, performed on the Pheno System. This is the first test to identify organisms that cause bloodstream infections and provide information about... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 23, 2017 Category: Pharmaceuticals Source Type: news

Louisiana Drug and Dietary Supplement Maker Ordered to Cease Operations Due to Federal Violations
February 21, 2017 -- On Friday, U.S. District Judge Robert G. James for the U.S. District Court for the Western District of Louisiana entered a consent decree of permanent injunction against Pick and Pay Inc./Cili Minerals, a manufacturer and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 21, 2017 Category: Pharmaceuticals Source Type: news

Monthly News Roundup - January 2017
Trulance Cleared by FDA for Chronic Idiopathic Constipation (CIC) The U.S. Food and Drug Administration (FDA) has approved Synergy’s Trulance (plecanatide), a uroguanylin analog for the treatment of chronic idiopathic constipation (CIC).... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 31, 2017 Category: Pharmaceuticals Source Type: news

FDA Approves Xyrem (sodium oxybate) Oral Solution Generic with a REMS Program
January 18, 2017 -- The FDA has approved the first generic version of Xyrem (sodium oxybate) Oral Solution, to treat cataplexy and excessive daytime sleepiness in patients with narcolepsy, which is a potentially debilitating disease. Cataplexy is a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 18, 2017 Category: Pharmaceuticals Source Type: news

Monthly News Roundup - December 2016
Biogen ’s Spinraza Approved for Spinal Muscular Atrophy The U.S. Food and Drug Administration (FDA) has cleared Biogen's Spinraza (nusinersen), the first drug for spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 31, 2016 Category: Pharmaceuticals Source Type: news

Monthly News Roundup - November 2016
Novo Nordisk ’s Xultophy 100/3.6 FDA-Approved for Type 2 Diabetes This month the U.S. Food and Drug Administration (FDA) approved Novo Nordisk’s Xultophy 100/3.6 (insulin degludec and liraglutide), a once-daily injection of insulin degludec... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 30, 2016 Category: Pharmaceuticals Source Type: news

Monthly News Roundup - October 2016
Merck ’s Zinplava Approved to Fend Off Return of Clostridium Difficile Zinplava (bezlotoxumab) has been FDA-approved to reduce the recurrence of Clostridium difficile infection (CDI) in adults who are receiving antibacterial drug treatment for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 31, 2016 Category: Pharmaceuticals Source Type: news